Current Cardiovascular Risk Reports最新文献

筛选
英文 中文
Virtual Cardiology: Past, Present, Future Directions, and Considerations. 虚拟心脏病学:过去、现在、未来的方向和注意事项。
IF 2
Current Cardiovascular Risk Reports Pub Date : 2023-01-01 Epub Date: 2023-05-29 DOI: 10.1007/s12170-023-00719-0
Gauranga Mahalwar, Ashish Kumar, Ankur Kalra
{"title":"Virtual Cardiology: Past, Present, Future Directions, and Considerations.","authors":"Gauranga Mahalwar, Ashish Kumar, Ankur Kalra","doi":"10.1007/s12170-023-00719-0","DOIUrl":"10.1007/s12170-023-00719-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Through this review, we attempt to explore the role of telemedicine and virtual visits in the field of cardiology pre-COVID-19 and during COVID-19 pandemic, their limitations and their future scope for delivery of care.</p><p><strong>Recent findings: </strong>Telemedicine, which rose to prominence during COVID-19 pandemic, helped not only in reducing the burden on the healthcare system during a time of crisis but also in improving patient outcomes. Patients and physicians also favored virtual visits when feasible. Virtual visits were found to have the potential to be continued beyond the pandemic and play a significant role in patient care alongside conventional face-to-face visits.</p><p><strong>Summary: </strong>Although tele-cardiology has proven beneficial in terms of patient care, convenience, and access, it comes with its fair share of limitations-both logistical and medical. Whilst there remains a great scope for improvement in the quality of patient care provided through telemedicine, it has shown the potential to become an integral part of medical practice in the future.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12170-023-00719-0.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 6","pages":"117-122"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9993513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Assessment and Management of Outflow Tract Arrhythmias Refractory to Prior Treatments 既往治疗难治流出道心律失常的风险评估和管理
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-12-19 DOI: 10.1007/s12170-022-00712-z
P. Futyma, Łukasz Zarębski, Shaojie Chen, A. Enriquez, H. Pürerfellner, P. Santangeli
{"title":"Risk Assessment and Management of Outflow Tract Arrhythmias Refractory to Prior Treatments","authors":"P. Futyma, Łukasz Zarębski, Shaojie Chen, A. Enriquez, H. Pürerfellner, P. Santangeli","doi":"10.1007/s12170-022-00712-z","DOIUrl":"https://doi.org/10.1007/s12170-022-00712-z","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"21-26"},"PeriodicalIF":1.9,"publicationDate":"2022-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49561185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Patient Education Strategies to Improve Risk of Stroke in Patients with Atrial Fibrillation 提高心房颤动患者卒中风险的患者教育策略
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-12-01 DOI: 10.1007/s12170-022-00709-8
Julio C Nunes, Shayena Shah, M. Fazal, Sofia E. Gomez, Chen Wei, Paul J. Wang, R. Stafford, T. Baykaner
{"title":"Patient Education Strategies to Improve Risk of Stroke in Patients with Atrial Fibrillation","authors":"Julio C Nunes, Shayena Shah, M. Fazal, Sofia E. Gomez, Chen Wei, Paul J. Wang, R. Stafford, T. Baykaner","doi":"10.1007/s12170-022-00709-8","DOIUrl":"https://doi.org/10.1007/s12170-022-00709-8","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"249-258"},"PeriodicalIF":1.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48227467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applying Interventions to Address the Social Determinants of Health and Reduce Health Disparities in Congenital Heart Disease Patients 应用干预措施解决健康的社会决定因素并减少先天性心脏病患者的健康差距
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-11-07 DOI: 10.1007/s12170-022-00710-1
Bianca Cherestal, Z. Hudson, Keila N. Lopez
{"title":"Applying Interventions to Address the Social Determinants of Health and Reduce Health Disparities in Congenital Heart Disease Patients","authors":"Bianca Cherestal, Z. Hudson, Keila N. Lopez","doi":"10.1007/s12170-022-00710-1","DOIUrl":"https://doi.org/10.1007/s12170-022-00710-1","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41927887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Workplace Meditation Interventions for Reducing Psychological Stress and Other Cardiovascular Risk Factors: Workplace Wellness Policy Implications 工作场所冥想干预减少心理压力和其他心血管危险因素:工作场所健康政策的影响
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-11-03 DOI: 10.1007/s12170-022-00708-9
Cheryl L. Woods-Giscombe, Jamie Conklin, Adam Dodd, Louise F. Barthold, Yvonne Perry, J. Brooks, Andrew Bradford, Sierra Vines, Raven Smith, E. Ikharo, Erum Agha, Aisha Chilcoat, Karen Sheffield-Abdullah, S. Gaylord
{"title":"Workplace Meditation Interventions for Reducing Psychological Stress and Other Cardiovascular Risk Factors: Workplace Wellness Policy Implications","authors":"Cheryl L. Woods-Giscombe, Jamie Conklin, Adam Dodd, Louise F. Barthold, Yvonne Perry, J. Brooks, Andrew Bradford, Sierra Vines, Raven Smith, E. Ikharo, Erum Agha, Aisha Chilcoat, Karen Sheffield-Abdullah, S. Gaylord","doi":"10.1007/s12170-022-00708-9","DOIUrl":"https://doi.org/10.1007/s12170-022-00708-9","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2022-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43734631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment 女性高血压:避孕、生育和激素治疗的影响
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-10-24 DOI: 10.1007/s12170-022-00705-y
G. Wilkie, Ekaterina Skaritanov, Micaela Tobin, Angela Essa, A. Gubala, L. Ferraro, Lara C Kovell
{"title":"Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment","authors":"G. Wilkie, Ekaterina Skaritanov, Micaela Tobin, Angela Essa, A. Gubala, L. Ferraro, Lara C Kovell","doi":"10.1007/s12170-022-00705-y","DOIUrl":"https://doi.org/10.1007/s12170-022-00705-y","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2022-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48915527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial Fibrillation in Women: from Epidemiology to Treatment 女性房颤:从流行病学到治疗
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-10-06 DOI: 10.1007/s12170-022-00707-w
K. Tamirisa, C. Dye, I. Ekeruo, A. Volgman
{"title":"Atrial Fibrillation in Women: from Epidemiology to Treatment","authors":"K. Tamirisa, C. Dye, I. Ekeruo, A. Volgman","doi":"10.1007/s12170-022-00707-w","DOIUrl":"https://doi.org/10.1007/s12170-022-00707-w","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"1 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2022-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41801256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention. 降低低密度脂蛋白胆固醇预防心血管疾病的新策略。
IF 2
Current Cardiovascular Risk Reports Pub Date : 2022-09-01 Epub Date: 2022-06-25 DOI: 10.1007/s12170-022-00694-y
Sean Paul Gaine, Renato Quispe, Jaideep Patel, Erin D Michos
{"title":"New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.","authors":"Sean Paul Gaine, Renato Quispe, Jaideep Patel, Erin D Michos","doi":"10.1007/s12170-022-00694-y","DOIUrl":"10.1007/s12170-022-00694-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>The primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on optimizing cardiovascular health and appropriate pharmacotherapy, a mainstay of which is low-density lipoprotein-cholesterol (LDL-C) lowering. Typically, statin therapy remains the first line approach. Advances in technology and understanding of lipid metabolism have facilitated the development of several novel therapeutic targets and medications within the last decade. This review focuses on medications recently approved by the U.S. Food and Drug Administration (FDA) for the reduction of LDL-C and ASCVD risk, as well as new therapies in the pipeline.</p><p><strong>Recent findings: </strong>Novel lipid therapies aim to lower risk of ASCVD by targeting reduction of atherogenic compounds, such as LDL, lipoprotein(a) (Lp(a)), and triglyceride-rich lipoproteins. Evolocumab and alirocumab, monoclonal antibody proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors which lower LDL-C by approximately 60%, have emerged as important therapies for use in patients with ASCVD as well as familial hypercholesterolemia (FH). Bempedoic acid, an ATP citrate lyase inhibitor, is an oral medication recently approved that can lower LDL-C by approximately 18% alone and 38% when combined with ezetimibe. Inclisiran, a small-interfering RNA (siRNA) molecule which inhibits the translation of PCSK9, is the most recently FDA-approved LDL-C lowering medication, and can reduce LDL-C by approximately 50% with twice yearly subcutaneous dosing. The cardiovascular outcome trials for bempedoic acid and inclisiran are still on-going. Evinacumab, a monoclonal antibody which targets angiopoietin-like protein 3 (ANGPTL3), has been approved for use in patients with homozygous FH. SiRNAs and anti-sense oligonucleotides (ASO) facilitating selective inhibition of the production of targeted proteins including Lp(a) and ANGLPTL3 are active areas of clinical investigation.</p><p><strong>Summary: </strong>Recently several novel LDL-C lowering medications have been approved. New therapeutic targets have been identified and present additional means of lowering LDL-C and other atherogenic compounds for patients who remain at high ASCVD risk.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 9","pages":"69-78"},"PeriodicalIF":2.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543364/pdf/nihms-1819176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10133436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Artery Calcium-Based Approach to Lipid Management 基于钙的冠状动脉脂质管理方法
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-08-19 DOI: 10.1007/s12170-022-00704-z
Ayeeshik Kole, P. Joshi
{"title":"Coronary Artery Calcium-Based Approach to Lipid Management","authors":"Ayeeshik Kole, P. Joshi","doi":"10.1007/s12170-022-00704-z","DOIUrl":"https://doi.org/10.1007/s12170-022-00704-z","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"1 1","pages":"1 - 14"},"PeriodicalIF":1.9,"publicationDate":"2022-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47924432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk 富含甘油三酯的脂蛋白、残留物与动脉粥样硬化性心血管疾病风险
IF 1.9
Current Cardiovascular Risk Reports Pub Date : 2022-07-23 DOI: 10.1007/s12170-022-00702-1
V. Bharadiya, Swasti Rawal, V. Jain, P. Chevli, Anurag Mehta
{"title":"Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk","authors":"V. Bharadiya, Swasti Rawal, V. Jain, P. Chevli, Anurag Mehta","doi":"10.1007/s12170-022-00702-1","DOIUrl":"https://doi.org/10.1007/s12170-022-00702-1","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"131 - 144"},"PeriodicalIF":1.9,"publicationDate":"2022-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45421694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书